CLINICAL RESEARCH: INVASIVE CARDIOLOGY
Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary InterventionThe Drug Elution and Distal Protection in ST-Elevation Myocardial Infarction (DEDICATION) Trial
Henning Kelbæk, MD*,
Christian J. Terkelsen, MD ,
Steffen Helqvist, MD*,
Jens F. Lassen, MD ,
Peter Clemmensen, MD*,
Lene Kløvgaard, RN*,
Anne Kaltoft, MD ,
Thomas Engstrøm, MD*,
Hans E. Bøtker, MD ,
Kari Saunamäki, MD*,
Lars R. Krusell, MD ,
Erik Jørgensen, MD*,
Hans-Henrik T. Hansen, MD*,
Evald H. Christiansen, MD ,
Jan Ravkilde, MD ,
Lars Køber, MD*,
Klaus F. Kofoed, MD* and
Leif Thuesen, MD ,*
* Department of Cardiology and Cardiac Catheterization Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.
Manuscript received August 16, 2007;
revised manuscript received October 10, 2007,
accepted October 22, 2007.
* Reprint requests and correspondence: Dr. Leif Thuesen, Department of Cardiology, Aarhus University Hospital, Skejby 8200 Aarhus N, Denmark. (Email: leif.thuesen{at}ki.au.dk).
Objectives: The purpose of this study was to evaluate the use of distal protection during percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) in native coronary vessels.
Background: Embolization of material from the infarct-related lesion during PCI may result in impaired myocardial perfusion and worsen the prognosis. Previous attempts to protect the microcirculation during primary PCI have had conflicting results.
Methods: We randomly assigned 626 patients with STEMI referred within 12 h to have PCI performed with (n = 312) or without (n = 314) distal protection. The primary end point was complete ( 70%) ST-segment resolution detected by continuous ST-segment monitoring. Blood levels of troponin-T and creatine kinase-MB were monitored before and after the procedure, and echocardiographic determination of the left ventricular wall motion index (WMI) was performed before discharge.
Results: Patients were well matched in terms of demographic and angiographic baseline characteristics. There was no significant difference in the occurrence of the primary end point (76% vs. 72%, p = 0.29), no difference in maximum troponin-T (4.8 µg/l and 5.0 µg/l, p = 0.87) or maximum creatine kinase-MB (185 µg/l and 184 µg/l, p = 0.99), and no difference in median WMI (1.70 vs. 1.70, p = 0.35). The rate of major adverse cardiac and cerebral events (MACCE) 1 month after PCI was 5.4% with distal protection and 3.2% with conventional treatment (p = 0.17).
Conclusions: The routine use of distal protection by a filterwire system during primary PCI does not seem to improve microvascular perfusion, limit infarct size, or reduce the occurrence of MACCE (Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction; NCT00192868
[ClinicalTrials.gov]
).
|
Abbreviations and Acronyms
| | ECG = electrocardiogram | | MACCE = major adverse cardiac and cerebral events | | PCI = percutaneous coronary intervention | | STEMI = ST-segment elevation myocardial infarction | | TLR = target lesion revascularization | | WMI = wall motion index |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. V. Sorensen, S. Pedersen, R. Mogelvang, J. Skov-Jensen, and A. Flyvbjerg
Plasma High-Mobility Group Box 1 Levels Predict Mortality After ST-Segment Elevation Myocardial Infarction
J. Am. Coll. Cardiol. Intv.,
March 1, 2011;
4(3):
281 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kaltoft, H. Kelbaek, L. Thuesen, J. F. Lassen, P. Clemmensen, L. Klovgaard, T. Engstrom, H. E. Botker, K. Saunamaki, L. R. Krusell, et al.
Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction: 3-Year Follow-Up of the Randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial
J. Am. Coll. Cardiol.,
August 17, 2010;
56(8):
641 - 645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kaltoft, H. Kelbaek, L. Klovgaard, C. J. Terkelsen, P. Clemmensen, S. Helqvist, J. F. Lassen, and L. Thuesen
Increased Rate of Stent Thrombosis and Target Lesion Revascularization After Filter Protection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: 15-Month Follow-Up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) Trial
J. Am. Coll. Cardiol.,
March 2, 2010;
55(9):
867 - 871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. L. Gu and F. Zijlstra
Chapter 36 Thrombus extraction in the contemporary management of ST-segment elevation myocardial infarction
Oxford Textbook of Interventional Cardiology,
January 1, 2010;
1(1):
med-9780199569083-chapter - med-9780199569083-chapter.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel
Coronary Microembolization: From Bedside to Bench and Back to Bedside
Circulation,
November 3, 2009;
120(18):
1822 - 1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D.E. Haeck, K. T. Koch, L. Bilodeau, R. J. Van der Schaaf, J. P.S. Henriques, M. M. Vis, J. Baan Jr, A. C. Van der Wal, J. J. Piek, J. G.P. Tijssen, et al.
Randomized Comparison of Primary Percutaneous Coronary Intervention With Combined Proximal Embolic Protection and Thrombus Aspiration Versus Primary Percutaneous Coronary Intervention Alone in ST-Segment Elevation Myocardial Infarction: The PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) Study
J. Am. Coll. Cardiol. Intv.,
October 1, 2009;
2(10):
934 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
June 2, 2009;
53(22):
2080 - 2097.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Busk, A. Kaltoft, S. S. Nielsen, M. Bottcher, M. Rehling, L. Thuesen, H. E. Botker, J. F. Lassen, E. H. Christiansen, L. R. Krusell, et al.
Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h
Eur. Heart J.,
June 1, 2009;
30(11):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Bavry, D. J. Kumbhani, and D. L. Bhatt
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials
Eur. Heart J.,
December 2, 2008;
29(24):
2989 - 3001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Terkelsen, J. T. Sorensen, and T. T. Nielsen
Is There Any Time Left for Primary Percutaneous Coronary Intervention According to the 2007 Updated American College of Cardiology/American Heart Association ST-Segment Elevation Myocardial Infarction Guidelines and the D2B Alliance?
J. Am. Coll. Cardiol.,
October 7, 2008;
52(15):
1211 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|